Regenxbio (RGNX) Leases (2019 - 2025)
Historic Leases for Regenxbio (RGNX) over the last 7 years, with Q3 2025 value amounting to $48.8 million.
- Regenxbio's Leases fell 1170.67% to $48.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $48.8 million, marking a year-over-year decrease of 1170.67%. This contributed to the annual value of $53.7 million for FY2024, which is 1119.41% down from last year.
- Latest data reveals that Regenxbio reported Leases of $48.8 million as of Q3 2025, which was down 1170.67% from $50.5 million recorded in Q2 2025.
- Regenxbio's Leases' 5-year high stood at $65.1 million during Q4 2022, with a 5-year trough of $48.8 million in Q3 2025.
- For the 5-year period, Regenxbio's Leases averaged around $58.7 million, with its median value being $60.2 million (2022).
- Its Leases has fluctuated over the past 5 years, first skyrocketed by 62125.07% in 2021, then crashed by 1170.67% in 2025.
- Over the past 5 years, Regenxbio's Leases (Quarter) stood at $60.9 million in 2021, then increased by 6.92% to $65.1 million in 2022, then dropped by 7.11% to $60.5 million in 2023, then dropped by 11.19% to $53.7 million in 2024, then fell by 9.11% to $48.8 million in 2025.
- Its Leases was $48.8 million in Q3 2025, compared to $50.5 million in Q2 2025 and $52.1 million in Q1 2025.